TripleMed

TripleMed

Year of investment: 2017

TripleMed is developing minimally invasive products against aneurysms, without the need for incisions.  The first product fills the aneurysm and prevents blood from entering, whilst leaving a channel for the blood to flow through to reach the other arteries. This enables a better and longer-lasting solution to the problem of aortic aneurysms.